They found that the positive rates of HDAC1, HDAC2, and HDAC3 expression were 36.4%, 57.9%, and 72.9%, respectively, in CRC tissues, and elevated HDAC levels significantly correlated with reduced patient survival[39, 40]. This evidence concerns the gene HDAC2 and colorectal carcinoma.